| |  | | | | By Megan Molteni Illustration: Alex Hogan/STAT; Photo: Rice University A picture has begun to emerge of the circumstances surrounding Michael Deem’s exit from academia and his attempts since then at a second act. Read More | | By Lev Facher and Damian Garde Elise Amendola/AP "The only thing I wonder is how another academic with limited government experience will help the nation," said one research epidemiologist. Read More | | By Angus Chen Molly Ferguson for STAT Here’s STAT’s comprehensive guide to the biology behind LAG-3, the buy-in from biopharma companies, and the roadblocks ahead. Read More | | Sponsor content by STAT Events The STAT Breakthrough Science Summit On March 31, take an inside look at the technologies and procedures set to redefine medicine, and change patient care in the years to come. You'll hear from the CEOs, scientists, entrepreneurs at the forefront of these efforts. Get your pass now, and use your STAT+ subscriber login to unlock a 20% discount. | | By Joseph G. Allen Mark Lennihan/AP The White House has announced it is elevating ventilation and "clean air in buildings" as a key pillar in the national Covid-19 response. Read More | | By Sneha Dave Adobe Research isn't complete unless it includes adolescents and young adults who end up taking the medications being tested. Read More | | By Anthony Yanni Adobe Biopharma companies need to include patients in decision-making on every step of drug development, something Robert Califf supports. Read More | |
No comments